TAC recently completed a feasibility study on the “Selection and characterisation of anti-peptide synthetic antibodies for comparison with conventional reagents”, funded by IBioIC. Read all about it here
IBioIC funded feasibility study Read More »
TAC was invited to give a talk on novel antibody production at the most recent ELRIG conference. Dr Jack Bryson presented “Production of Monoclonal Antibodies using a Phage-Display scFv Library: a Faster, More Flexible, and More Secure Complement to Hybridoma”. This generated a lot of discussion with some very interesting proposals for projects utilising this
ELRIG – THE SCOTTISH RESEARCH AND DRUG DEVELOPMENT FORUM Read More »
The Antibody Company, TAC, has been recognised for high standards of excellence with silver accreditation from North Lanarkshire Council’s Employer Charter. The charter is based around four commitments by employers: to pay all staff at minimum the Real Living Wage; employ North Lanarkshire residents; use local businesses in the supply chain where possible; and ensure fair work practices
North Lanarkshire Council employer award for The Antibody Company Read More »